USPTO serial 87070319
CANCERNET
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- HALMEN, KATHERINE E
- Law office
- TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with CANCERNET?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Mountain View, CA
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Assays for research purposes; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for scientific use; Diagnostic reagents for scientific or research use; Reagents for research purposes; Reagents for scientific or medical research use; Assays and reagents for use in genetic research; Diagnostic preparations for scientific or research use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology | ACTIVE | Feb 25, 2016 |
| 005 | Diagnostic biomarker reagents for medical purposes; Diagnostic reagents for medicinal use; Medical diagnostic reagents; Medical diagnostic reagents for the analysis of body fluids; Reagents for medical use; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, sepsis; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Reagents and media for medical and veterinary diagnostic purposes | ACTIVE | Feb 25, 2016 |
| 042 | Biological research; Biomedical research services; DNA analysis services for scientific research purposes; Laboratory research services relating to pharmaceuticals; Laboratory research in the field of genetics; Medical laboratory services; Medical research services in the field of cancer; Pharmaceutical research and development; Product research and development; Research and development of new products; Research on the subject of pharmaceuticals; Scientific laboratory services; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Research and development and consultation related thereto in the field of genetics; Research and development of new products for others; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of technology in the field of genetics; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines | ACTIVE | Feb 25, 2016 |
| 044 | Health care services, namely, providing a database in the field of cancer information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Medical diagnostic testing, monitoring and reporting services; Medical screening services in the field of cancer; Medical testing for diagnostic or treatment purposes; Genetic testing of animals for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of cancer; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals | ACTIVE | Feb 25, 2016 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cellecta, Inc
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CANCERNET
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 12, 2017 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 12, 2017 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 14, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 20, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 17, 2016 | NWAP | NEW APPLICATION ENTERED | — |